Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Oct 26;97(17):813-816.
doi: 10.1212/WNL.0000000000012737. Epub 2021 Sep 8.

Sporadic Creutzfeldt-Jakob Disease in a Very Young Person

Affiliations
Comment

Sporadic Creutzfeldt-Jakob Disease in a Very Young Person

Brian Stephen Appleby et al. Neurology. .

Abstract

Background and objectives: Sporadic Creutzfeldt-Jakob disease (sCJD) is the most common form of human prion disease and typically occurs in middle to late life. sCJD in early adulthood is extremely uncommon. The purpose of this report is to raise awareness of cases of sCJD in young patients that are not associated with a genetic mutation or acquired prion disease risk factors.

Methods: We describe the clinical presentation, diagnostic workup, and postmortem examination of a 22-year-old man with sCJD.

Results: The patient presented with a rapidly progressive neurocognitive disorder consisting of early and prominent psychiatric symptoms. CSF real-time quaking-induced conversion (RT-QuIC) was indeterminate, and brain MRI was suggestive of prion disease. Neuropathologic examination and the absence of a genetic mutation and acquired prion disease risk factors resulted in a final diagnosis of sCJD.

Conclusion: Although extremely rare, sCJD can occur in young people and should be considered in the setting of rapidly progressive neuropsychiatric conditions. Postmortem examination is required to diagnose the type of prion disease and remains important to surveil for known and potentially novel acquired prion diseases.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Brain MRI 3 Months After Symptom Onset
Hyperintensity is seen in most cortices and bilateral caudate heads on diffusion-weighted imaging (A) and fluid-attenuated inversion recovery (B) sequences. Attenuation of the signal is noted in some cortical areas on apparent diffusion coefficient (C).
Figure 2
Figure 2. Histopathology
Hematoxylin & eosin (A and C) and immunohistochemistry (B and D) of prion protein. (A and C) Spongiform degeneration with medium size; vacuoles (arrow). (B and D) Faint PrP immunostaining with synaptic pattern. Antibody: 3F4; size bar: 100 µm.

Comment in

Comment on

References

    1. Maddox RA, Person MK, Blevins JE, et al. Prion disease incidence in the United States, 2003-2015. Neurology. 2020;94(2):e153-e157. - PubMed
    1. Thompson AGB, Lowe J, Fox Z, et al. The Medical Research Council prion disease rating scale: a new outcome measure for prion disease therapeutic trials developed and validated using systematic observational studies. Brain. 2013;136(pt 4):1116-1127. - PubMed
    1. Rhoads DD, Wrona A, Foutz A, et al. Diagnosis of prion diseases by RT-QuIC results in improved surveillance. Neurology. 2020;95(8):e1017-e1026. - PubMed
    1. Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol. 1999;46(2):224-233. - PubMed
    1. Meissner B, Westner IM, Kallenberg K, et al. Sporadic Creutzfeldt-Jakob disease: clinical and diagnostic characteristics of the rare VV1 type. Neurology. 2005;65(10):1544-1550. - PubMed

Publication types